Anticomplement treatment of PNH in the era of Eculizumab: problems and outlook.
10.3760/cma.j.issn.0253-2727.2014.03.024
- Author:
Zhijie WU
1
;
Fengkui ZHANG
1
Author Information
1. Institute of Hematology and Blood Diseases Hospital, CAMS & PUMC, Tianjin 300020, China.
- Publication Type:Journal Article
- MeSH:
Antibodies, Monoclonal, Humanized;
therapeutic use;
Complement Inactivator Proteins;
therapeutic use;
Hemoglobinuria, Paroxysmal;
therapy;
Humans
- From:
Chinese Journal of Hematology
2014;35(3):266-268
- CountryChina
- Language:Chinese
